Jun 16, 2025
Оfftopic Community
Оfftopic Community
Forums
New posts
Search forums
What's new
Featured content
New posts
New media
New media comments
New resources
New profile posts
Latest activity
Media
New media
New comments
Search media
Resources
Latest reviews
Search resources
Members
Current visitors
New profile posts
Search profile posts
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Install the app
Install
Forums
Information & News
RSS News
Health and Fitness
Cellceutix Signs Agreements For KevetrinTM Phase 1 Support; Company Continues To Adva
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="tD33NAt" data-source="post: 2170024" data-attributes="member: 124445"><p>Cellceutix Corporation (OTCBB: CTIX), a bio-pharmaceutical company that develops small molecules to treat cancer, autism and inflammatory disease, announced that it has concluded agreements with PharPoint Reasearch for Phase 1 data management and statistical analysis and with Medical Research Consulting Services for Phase 1 clinical monitoring. The terms of the agreements were not disclosed. These agreements provide the basic resources necessary to conduct the Phase 1 study of the Company's cancer compound, Kevetrin... <a href="http://feedads.g.doubleclick.net/~a/y0G7QjQFr04_ll0ymQ8KBWgs2uc/0/da" target="_blank"><img src="http://feedads.g.doubleclick.net/~a/y0G7QjQFr04_ll0ymQ8KBWgs2uc/0/di" alt="" class="fr-fic fr-dii fr-draggable " data-size="" style="" /></a></p><p><a href="http://feedads.g.doubleclick.net/~a/y0G7QjQFr04_ll0ymQ8KBWgs2uc/1/da" target="_blank"><img src="http://feedads.g.doubleclick.net/~a/y0G7QjQFr04_ll0ymQ8KBWgs2uc/1/di" alt="" class="fr-fic fr-dii fr-draggable " data-size="" style="" /></a></p><p></p><p><img src="http://feeds.feedburner.com/~r/mnt/healthnews/~4/MQwnxssu55w" alt="" class="fr-fic fr-dii fr-draggable " data-size="" style="" /></p><p></p><p><a href="http://feedproxy.google.com/~r/mnt/healthnews/~3/MQwnxssu55w/3D2f" target="_blank">More...</a></p></blockquote><p></p>
[QUOTE="tD33NAt, post: 2170024, member: 124445"] Cellceutix Corporation (OTCBB: CTIX), a bio-pharmaceutical company that develops small molecules to treat cancer, autism and inflammatory disease, announced that it has concluded agreements with PharPoint Reasearch for Phase 1 data management and statistical analysis and with Medical Research Consulting Services for Phase 1 clinical monitoring. The terms of the agreements were not disclosed. These agreements provide the basic resources necessary to conduct the Phase 1 study of the Company's cancer compound, Kevetrin... [URL="http://feedads.g.doubleclick.net/~a/y0G7QjQFr04_ll0ymQ8KBWgs2uc/0/da"][IMG]http://feedads.g.doubleclick.net/~a/y0G7QjQFr04_ll0ymQ8KBWgs2uc/0/di[/IMG][/URL] [URL="http://feedads.g.doubleclick.net/~a/y0G7QjQFr04_ll0ymQ8KBWgs2uc/1/da"][IMG]http://feedads.g.doubleclick.net/~a/y0G7QjQFr04_ll0ymQ8KBWgs2uc/1/di[/IMG][/URL] [IMG]http://feeds.feedburner.com/~r/mnt/healthnews/~4/MQwnxssu55w[/IMG] [url=http://feedproxy.google.com/~r/mnt/healthnews/~3/MQwnxssu55w/3D2f]More...[/url] [/QUOTE]
Insert quotes…
Name
Verification
Please enable JavaScript to continue.
Loading…
Post reply
Top